1999
DOI: 10.1104/pp.120.3.833
|View full text |Cite
|
Sign up to set email alerts
|

Arabidopsis det2 Is Defective in the Conversion of (24R)-24-Methylcholest-4-En-3-One to (24R)-24-Methyl-5α-Cholestan-3-One in Brassinosteroid Biosynthesis1

Abstract: Previously, we have shown that the Arabidopsis det2 (deetiolated2) mutant is defective in the biosynthesis of brassinosteroids (BR) and that DET2 (a steroid 5␣-reductase) acts early in the proposed BR biosynthetic pathway. In this paper we present further biochemical characterization of det2. We have undertaken metabolic experiments with 2 H-labeled substrates of intermediates involved in the formation of campestanol from campesterol, and quantitative analysis of intermediates in Arabidopsis wild type and det2… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
92
0

Year Published

2001
2001
2018
2018

Publication Types

Select...
5
4

Relationship

2
7

Authors

Journals

citations
Cited by 157 publications
(97 citation statements)
references
References 34 publications
2
92
0
Order By: Relevance
“…Mutants det2 presented only 8-15% of the campestanol levels found in the wild type and less than 10% of the wild type levels of other BRs. Mutants det2 were also unable to convert H 2 -campesterol into H 2 -campestanol, demonstrating that det2 mutantes were deficient in brassinoesteroids (reviewed in Li and Chory, 1999). Additional support to this finding came from rescue experiments in which all intermediates of the BRs biosynthetic pathway after the reaction catalyzed by det2 were able to rescue det2 mutant phenotypes (Li et al, 1996;Li and Chory, 1999).…”
Section: Cpdsupporting
confidence: 59%
See 1 more Smart Citation
“…Mutants det2 presented only 8-15% of the campestanol levels found in the wild type and less than 10% of the wild type levels of other BRs. Mutants det2 were also unable to convert H 2 -campesterol into H 2 -campestanol, demonstrating that det2 mutantes were deficient in brassinoesteroids (reviewed in Li and Chory, 1999). Additional support to this finding came from rescue experiments in which all intermediates of the BRs biosynthetic pathway after the reaction catalyzed by det2 were able to rescue det2 mutant phenotypes (Li et al, 1996;Li and Chory, 1999).…”
Section: Cpdsupporting
confidence: 59%
“…The genetic approach used to identify the components of the BR biosynthetic and signal transduction pathways have relied on the isolation and characterization of mutants deficient in BRs biosynthesis or response. The availability of these mutants has played a major role in the increase in the knowledge concerning BRs Li and Chory, 1999;Bishop and Yokota, 2001;Clouse, 2002). BR-deficient mutants usually result from lesions in genes encoding for BR biosynthetic enzymes and are rescued to the wild type phenotype by exogenously supplied BRs Choe et al, 1998Choe et al, , 2000.…”
Section: Introductionmentioning
confidence: 99%
“…7B). The phenotype of the rcd1-3; sro1-1 double mutant seedlings superficially resembles that of mutations in components of the brassinosteroid biosynthetic pathway, such as det2 mutants (Noguchi et al, 1999); however, the double mutant seedlings do expand their leaves, in a manner similar to the wild type, when exposed to exogenous brassinosteroid (Fig. 7D).…”
Section: Conditionsmentioning
confidence: 99%
“…DET2 encodes a steroid 5a-reductase that catalyzes a key step in BR biosynthesis (Noguchi et al, 1999). This close proximity raised the possibility that the large-leaf phenotype we attributed to a disruption of PHT4;2 was instead caused by an overexpression of DET2 via T-DNA activation (Weigel et al, 2000;Ren et al, 2004).…”
Section: Plant Size and Biomassmentioning
confidence: 99%